Literature DB >> 21717034

Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease.

Noemí Fabelo1, Virginia Martín, Gabriel Santpere, Raquel Marín, Laia Torrent, Isidre Ferrer, Mario Díaz.   

Abstract

Lipid rafts are cholesterol- and sphingomyelin-enriched microdomains that provide a highly saturated and viscous physicochemical microenvironment to promote protein-lipid and protein-protein interactions. We purified lipid rafts from human frontal cortex from normal, early motor stages of Parkinson's disease (PD) and incidental Parkinson's disease (iPD) subjects and analyzed their lipid composition. We observed that lipid rafts from PD and iPD cortices exhibit dramatic reductions in their contents of n-3 and n-6 long-chain polyunsaturated fatty acids, especially docosahexaenoic acid (22:6-n3) and arachidonic acid (20:4n-6). Also, saturated fatty acids (16:0 and 18:0) were significantly higher than in control brains. Paralleling these findings, unsaturation and peroxidability indices were considerably reduced in PD and iPD lipid rafts. Lipid classes were also affected in PD and iPD lipid rafts. Thus, phosphatidylserine and phosphatidylinositol were increased in PD and iPD, whereas cerebrosides and sulfatides and plasmalogen levels were considerably diminished. Our data pinpoint a dramatic increase in lipid raft order due to the aberrant biochemical structure in PD and iPD and indicate that these abnormalities of lipid rafts in the frontal cortex occur at early stages of PD pathology. The findings correlate with abnormal lipid raft signaling and cognitive decline observed during the development of these neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21717034      PMCID: PMC3188884          DOI: 10.2119/molmed.2011.00119

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  58 in total

Review 1.  Ceramide in the eukaryotic stress response.

Authors:  Y A Hannun; C Luberto
Journal:  Trends Cell Biol       Date:  2000-02       Impact factor: 20.808

2.  Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex.

Authors:  Virginia Martín; Noemí Fabelo; Gabriel Santpere; Berta Puig; Raquel Marín; Isidre Ferrer; Mario Díaz
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  VDAC and ERalpha interaction in caveolae from human cortex is altered in Alzheimer's disease.

Authors:  Cristina M Ramírez; Miriam González; Mario Díaz; Rafael Alonso; Isidre Ferrer; Gabriel Santpere; Berta Puig; Gundela Meyer; Raquel Marin
Journal:  Mol Cell Neurosci       Date:  2009-07-10       Impact factor: 4.314

Review 4.  A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer's disease and Parkinson's disease with dementia.

Authors:  Claudia Metzler-Baddeley
Journal:  Cortex       Date:  2007-07       Impact factor: 4.027

Review 5.  The challenge of lipid rafts.

Authors:  Linda J Pike
Journal:  J Lipid Res       Date:  2008-10-27       Impact factor: 5.922

6.  Increased oxidation of certain glycolysis and energy metabolism enzymes in the frontal cortex in Lewy body diseases.

Authors:  Anna Gómez; Isidre Ferrer
Journal:  J Neurosci Res       Date:  2009-03       Impact factor: 4.164

7.  Docosahexaenoic acid modifies the clustering and size of lipid rafts and the lateral organization and surface expression of MHC class I of EL4 cells.

Authors:  Saame Raza Shaikh; Benjamin Drew Rockett; Muhammad Salameh; Kristen Carraway
Journal:  J Nutr       Date:  2009-07-29       Impact factor: 4.798

Review 8.  Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects.

Authors:  Isidre Ferrer
Journal:  Prog Neurobiol       Date:  2009-03-09       Impact factor: 11.685

Review 9.  A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.

Authors:  Kurt A Jellinger
Journal:  Biochim Biophys Acta       Date:  2008-08-05

Review 10.  Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease.

Authors:  Isidre Ferrer
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

View more
  114 in total

1.  Dietary fat intake, pesticide use, and Parkinson's disease.

Authors:  Freya Kamel; Samuel M Goldman; David M Umbach; Honglei Chen; Gina Richardson; Marie Richards Barber; Cheryl Meng; Connie Marras; Monica Korell; Meike Kasten; Jane A Hoppin; Kathleen Comyns; Anabel Chade; Aaron Blair; Grace S Bhudhikanok; G Webster Ross; J William Langston; Dale P Sandler; Caroline M Tanner
Journal:  Parkinsonism Relat Disord       Date:  2013-10-01       Impact factor: 4.891

2.  Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein.

Authors:  Emma I O'Leary; Zhiping Jiang; Marie-Paule Strub; Jennifer C Lee
Journal:  J Biol Chem       Date:  2018-05-31       Impact factor: 5.157

Review 3.  A biological perspective of CSF lipids as surrogate markers for cognitive status in HIV.

Authors:  Norman J Haughey; Xiaomao Zhu; Veera Venkata Ratnam Bandaru
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-08       Impact factor: 4.147

Review 4.  Parkinson's disease: proteinopathy or lipidopathy?

Authors:  Saranna Fanning; Dennis Selkoe; Ulf Dettmer
Journal:  NPJ Parkinsons Dis       Date:  2020-01-03

5.  Toll Like Receptor 4 Affects the Cerebral Biochemical Changes Induced by MPTP Treatment.

Authors:  Carmela Conte; Luca Roscini; Roccaldo Sardella; Giuseppina Mariucci; Stefania Scorzoni; Tommaso Beccari; Laura Corte
Journal:  Neurochem Res       Date:  2017-01-21       Impact factor: 3.996

Review 6.  Tied up: Does altering phosphoinositide-mediated membrane trafficking influence neurodegenerative disease phenotypes?

Authors:  Sravanthi S P Nadiminti; Madhushree Kamak; Sandhya P Koushika
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 7.  Peroxisomal Dysfunction in Age-Related Diseases.

Authors:  Cynthia M Cipolla; Irfan J Lodhi
Journal:  Trends Endocrinol Metab       Date:  2017-01-04       Impact factor: 12.015

8.  Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids.

Authors:  Anna Caretti; Michele Vasso; Fabiola Tecla Bonezzi; Andrea Gallina; Marco Trinchera; Alice Rossi; Raffaella Adami; Josefina Casas; Monica Falleni; Delfina Tosi; Alessandra Bragonzi; Riccardo Ghidoni; Cecilia Gelfi; Paola Signorelli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-04-24       Impact factor: 3.000

9.  Parkinson's Disease Master Regulators on Substantia Nigra and Frontal Cortex and Their Use for Drug Repositioning.

Authors:  D M Vargas; M A De Bastiani; R B Parsons; F Klamt
Journal:  Mol Neurobiol       Date:  2020-11-19       Impact factor: 5.590

Review 10.  Interplay between α-synuclein amyloid formation and membrane structure.

Authors:  Emma I O'Leary; Jennifer C Lee
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2018-10-02       Impact factor: 3.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.